Question 1: Radioligands that bind to ________ (D1,D2, reuptake transporter), serotonin receptors (5HT1A, 5HT2A, reuptake transporter) opioid receptors (mu) and other sites have been used successfully in studies with human subjects.
Question 3: As the radioisotope undergoes positron emission decay (also known as positive ________), it emits a positron, an antiparticle of the electron with opposite charge.
Question 4: In the 1970s, Tatsuo Ido at the Brookhaven National Laboratory was the first to describe the synthesis of 18F-________, the most commonly used PET scanning isotope carrier.
Question 6: The system detects pairs of ________ emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on a biologically active molecule.
Question 7: Positron emission tomography (PET) is a ________imaging technique which produces a three-dimensional image or picture of functional processes in the body.
Question 8: This means that FDG is trapped in any cell which takes it up, until it decays, since ________ sugars, due to their ionic charge, cannot exit from the cell.
Question 9: This can also be compared to 2.2 mSv average annual ________ in the UK, 0.02 mSv for a chest x-ray and 6.5 - 8 mSv for a CT scan of the chest, according to the Chest Journal and ICRP.
Question 10: [9][10] A policy change suggested by the ________ member associations in year 1999 mentioned that an aircrew member is likely to receive a radiation dose of 4–9 mSv per year.